|
|
|
|
|
市場調査レポート
トランスフェクション・ライフサイエンスの動向：シリーズ2
Transfection Life Science Dashboard Series 2
|
Abstract
The ability to transfect DNA into mammalian cells and cell lines is a critical
step in the analysis of gene expression, protein structure and function and
molecular interactions within the cell. The Transfection Dashboard Series Two
was developed from responses to a 24-question survey completed by over 427
scientists predominantly located in North America and Europe. This Dashboard
reveals key market indicators for the transfection market as a whole as well
as for the following sub-segments:
- Chemically-mediated transfection (i.e. calcium phosphate)
- Lipid-mediated transfection
- Instrument-mediated transfection (i.e. electroporator, NucleofectorR)
Virus-mediated transfection (Note: for the purposes of this report,
virus-mediated transfection refers to the delivery of nucleic acid material
into mammalian cells or cell lines using virus and/or viral-based gene
delivery systems).
The genomics revolution has set the table for the study of gene expression &
regulation as well as protein structure and function. The technique of
transfection
Table of Contents
- 6. Figures and Tables
- 10. Executive Summary
- 12. Key Findings and Implications
- 15. Transfection Dashboard
- 19. Transfection Market Opportunity Matrix
- 21. Survey Methodology
- 22. Survey Invitation Text
- 24. Respondent Demographics
- 37. Frequency of Performance of Life Science Techniques
- 42. Frequency of Transfection of Mammalian Cells or Cell Lines
- 54. Reaction Throughput and Market Growth Rates
- 60. Respondent' s Stated Price Per Reaction
- 63. Total Market Size, Market Segment Sizes and Total Market Growth
Rate
- 66. Market Shares for Products for Chemically-Mediated Transfection
of Mammalian Cells or Cell Lines
- 70. Market Shares for Products for Lipid-Mediated Transfection of
Mammalian Cells or Cell Lines
- 74. Market Shares for Products for Instrument-Mediated Transfection
of Mammalian Cells or Cell Lines
- 78. Market Shares for Products for Virus-Mediated Transfection of
Mammalian Cells or Cell Lines
- 83. Customer Satisfaction And Interest In Switching Suppliers
- 90. Product Features That Influence Purchasing Decisions
- 94. Primary and Secondary Downstream Applications
- 114. Desired Changes to Transfection Products
- 122. Survey Questionnaire 26
FIGURES:
- Figure 1: Respondent' s Place of Employment
- Figure 2: Respondent' s Country/Region
- Figure 3: Respondent' s Job Title
- Figure 4: Respondent' s Areas of Expertise/Specialization
- Figure 5: Number of Employees in Respondent' s Laboratories
- Figure 6: Percentage of Respondents Performing Various Life Science
Techniques at Least a Few Times per Year
- Figure 7: Percentage of Respondents Transfecting Mammalian Cells or
Cell Lines
- Figure 8: Percentage of Respondents Performing Transfection of
Mammalian Cells or Cell Lines at Least a Few Times Per Year
- Figure 9: Percentage of Respondents Performing Chemically-Mediated
Transfection of Mammalian Cells or Cell Lines
- Figure 10: Percentage of Respondents Performing Lipid-Mediated
Transfection of Mammalian Cells or Cell Lines
- Figure 11: Percentage of Respondents Performing Instrument-Mediated
Transfection of Mammalian Cells or Cell Lines
- Figure 12: Percentage of Respondents Performing Virus-Mediated
Transfection of Mammalian Cells or Cell Lines
- Figure 13: Respondent' s Primary Supplier for Chemically-Mediated
Transfection of Mammalian Cells or Cell Lines
- Figure 14: Respondent' s Primary Supplier for Lipid-Mediated
Transfection of Mammalian Cells or Cell Lines
- Figure 15: Respondent' s Primary Supplier for Instrument-Mediated
Transfection of Mammalian Cells or Cell Lines
- Figure 16: Respondent' s Primary Supplier for Virus-Mediated
Transfection of Mammalian Cells or Cell Lines
- Figure 17: Percentage of Respondents That Have Switched Suppliers
in the Last Six Months
- Figure 18: Percentage of Respondents That Have Switched from the
following Suppliers to a Different Supplier in the Last Six Months
- Figure 19: Most Important Features of Transfection Products
- Figure 20: Respondent' s Primary Application for Mammalian Cells or
Cell Lines After Chemically-Mediated Transfection
- Figure 21: Respondent' s Primary and Secondary Applications for
Mammalian Cells or Cell Lines After Chemically-Mediated Transfection
- Figure 22: Respondent' s Primary Application for Mammalian Cells or
Cell Lines After Lipid-Mediated Transfection
- Figure 23: Respondent' s Primary and Secondary Applications for
Mammalian Cells or Cell Lines After Lipid-Mediated Transfection
- Figure 24: Respondent' s Primary Applications for Mammalian Cells or
Cell Lines After Instrument-Mediated Transfection
- Figure 25: Respondent' s Primary and Secondary Applications for
Mammalian Cells or Cell Lines After Instrument-Mediated Transfection
- Figure 26: Respondent' s Primary Applications for Mammalian Cells or
Cell Lines After Virus-Mediated Transfection
- Figure 27: Respondent' s Primary and Secondary Applications for
Mammalian Cells or Cell Lines After Instrument-Mediated Transfection
|
 |
